In 2021 and 2022, MinacNed will host pre-events leading up to the international MicroNanoConference 2022. The symposia are live events in The Netherlands, offering an interesting program with speakers from industry and science, with an opportunity for networking.

On November 23, a Micro Nano Symposium will be organised around the 2021 Groeifonds application. The consortium of partners from science and industry responsible for program will celebrate the submission of their application, specifically the focus theme Biomedical production technology under the NXTGen High Tech

From Science to Market: Biomedical Production Technology

Biomedical production technology fails to keep pace with innovations in the biomedical domain. The (academic) knowledge in the Netherlands is at a very high level in the field of Lab-on-Chip, Organ-on-Chip, Artificial Organs and Cell production technology, but is not (properly) converted into products. The main reason for this is that a multidisciplinary chain is required of suppliers of high-quality specific components in both the technological and biological field. Although the required parties are present in the Netherlands, their production equipment and processes are not yet compatible with each other. These major challenges cannot be solved by a few parties, but a large collaboration is needed to be able to design and functionally qualify products from the existing developed building blocks (e.g., sensors, chips, biomaterials) in order to subsequently achieve upscaling and the growing (world) market.

MinacNed, hDMT, MESA+ and Nano4Society organize a pre-event of the international MicroNano Conference 2022 to address this topic and will present steps that are currently being taken to establish an ecosystem with a unique and first-of-its-kind production chain in the Netherlands.

hDMT partner Minacned

Organizers:   hDMT, MinacNed, MESA+, Nano4Society
Date:               23 November 2021, 14.00 – 17.00
Location:      The Gallery,  University of Twente, Enschede
(The Gallery, Hengelosestraat 500, 7521 AN Enschede)

Preliminary program

13.30 – 14.00  Arrival with coffee and tea

14.00 – 14.10 Opening and welcome, Janny van den Eijnden-van Raaij (chair, hDMT) and Albert van den Berg (MESA+)

14.10 – 14.40  Tom van der Horst (TNO), Overview NXTGEN HIGHTECH
14.40 – 15.10  Berend van Meer (hDMT): “A national ecosystem for biomedical production technologies”

15.10 – 15.40  Coffee Break and networking

 15.40 – 16.10  Marko Blom (Micronit, Enschede),  NXTGEN HIGHTECH: perspective from high tech industry: “Challenges and solutions for scaling from fabrication of prototypes to repetitive manufacturing”
16.10 – 16.40  Jasper Boomker (Kidney Foundation) NXTGEN HIGHTECH: perspective from end user: “Closing innovation gaps: the case of the artificial kidney”

16.40 – 17.00  Panel discussion

17:00-17:30 Drinks and networking

Invited keynote speakers include science and industry partners, a government overview of the importance of these partnerships and the point of view from an end user. After these great talks, the inspired attendees can meet and greet in a network setting with drinks to formalize future partnerships. The event is  a live event in Enschede, at the location The Gallery.

You can now register (free of charge) to attend the event for one of the limited seats.

Registration Micro Nano Symposium
From Science to Market: Biomedical Production Technology

The international MicroNanoConference is the MinacNed conference for and by members. We are organizing this conference together with a group of members from both industry and science. These enthusiastic volunteers bring their own background and network to set up a program for the iMNC21.

From surveys we have taken after past iMNC events we have learned that participants see great value in the networking opportunities at the iMNC. An online platform offers fewer networking opportunities, therefore the organization has focused on an event in the Jaarbeurs, Utrecht.

With that in mind, this year’s iMNC21 location had been reserved, an international group of speakers had been invited and a fantastic program was set up that addresses both technical themes and more societal themes. However, for a successful event we not only need a well-organized and substantive program, but above all we also need the commitment and support of participants and exhibitors.

In these times of great uncertainty due to the Covid-19 measures, it turns out to be extremely difficult to get sufficient certainty in time to organize a conference with a large (international) participation.

As a result, we saw two risks arising. There was a risk (due to insufficient participants and sponsors) that the costs would be higher than the income. There was an equally great risk for participants and for exhibitors who invest in an event that would not offer sufficient networking opportunities to achieve the objectives. As MinacNed and the entire team organizing the iMNC21, we must avoid these risks. That is why the MinacNed board has unfortunately had to decide to cancel the iMNC21 conference this year.

The board of MinacNed would like to thank all members, OC and PC committee members and all those involved who have already committed themselves to the preparations for their contributions and also apologize because these preparations will unfortunately not lead to the iMNC21.

The team is currently working out whether the lecture program that has been put together for iMNC21 can be presented in a different way. This could be organized either in small local events or online. It is not yet clear in what form and on what dates these events will take place. We will keep you informed.

iMNC21 cancelled – explantation from MinacNed board (pdf)

The ‘Groeifonds’ proposal NXTGEN HIGHTECH is selected to be worked out in detail to be submitted in October 2021. The Netherlands is an international leader when it comes to ultra-precision high-tech equipment and aims to exploit this expertise in NXTGEN HIGHTECH for production of Organs-on-Chips, among others. In total, 28 projects were selected from 244 initial submissions.

The ‘Topsector HTSM’ has, in close collaboration with knowledge institutes, governments, industry and other topsectors, initiated this widely supported programme (budget € ~1.5 billion) to develop the next generation High Tech Equipment for these industries. One of the six domains of NXTGEN HIGHTECH is ‘Biomedical Production Technologies’ and is being coordinated by Berend van Meer on behalf of hDMT. This domain aims at large scale production of Labs-on-Chips, Organs-on-Chips, Artificial Organs and Cell Production Equipment, in which industrial standardisation and qualification are indispensable.

In case the project will be funded, hDMT partners will be involved closely in the further elaboration and setup of the next steps. For more information about NXTGEN HIGHTECH see and about the National ‘Groeifonds’ see

Several MedTech initiatives from Twente have been awarded REACT-EU funding. The millions in subsidies will give the relevant companies and researchers in Twente an enormous boost, demonstrate the potential of MedTech in the region and strengthen Kennispark Twente as a MedTech hotspot.

Green light for MedTech Factory

In the MedTech Factory, start-up and fast-growing companies in medical technology will soon have access to high-quality and affordable microbiology labs. They can rent flexible space at the MedTech Factory until they are large enough to have their own building. The concept can be realised by initiators Novel-T and Kennispark Twente with the 3.1 million EFRO subsidy and the contribution already allocated from the RegioDeal via TwenteBoard.

Together with its regional partners, Novel-T recently presented its ambition to give the MedTech cluster in Twente a solid boost in the coming years. In September 2020, Jaap Beernink (CEO of Novel-T) and Eddy van Hijum (member of the Provincial Executive of Overijssel) presented an investment agenda on behalf of the regional cluster to State Secretary Mona Keijzer. On this agenda, affordable lab facilities were high on the priority list.

Anne-Wil Lucas, Area Director of Kennispark: “This grant is fantastic news for the region and Kennispark Twente. Without these subsidies, such facilities would never get off the ground, while they are essential for the continued growth of companies. This will ensure that we can retain Twente’s MedTech companies and attract companies from outside Twente.”

Consortia of knowledge institutes and Twente MedTech companies

In addition to the MedTech Factory, the other REACT-EU awards include various consortia of Twente MedTech companies and the University of Twente. These are collaborations that aim to use medical technology to contribute to an improved and affordable healthcare sector. These projects demonstrate the innovative capacity and power of cooperation within the regional cluster.

Innovations for the treatment of dementia and improved detection of breast cancer

For example, over 1.5 million euros was awarded to the ‘reMIND’ initiative, in which Demcon, Micronit and Locsens are consortium partners. Within reMIND, the parties bring together four different technologies to better treat dementia.

A second consortium, consisting of PA Imaging, Hemabo and the University of Twente in collaboration with Radboud UMC, will receive up to EUR 2.6 million for bringing photo-acoustic mammography to the patient.

A third example is the consortium formed around LioniX International, which includes Bronkhorst High-Tech, SurfiX, Qurin Diagnostics and PHIX. Together they are working on the SensorChip aimed at developing various types of gas, liquid and biosensors. They will receive over EUR 2.5 million for this project.

Finally, the Enschede-based company ILT Fineworks is involved in the industrialisation of the ELENA Heart Technology, for which a maximum of 1.7 million euros has been granted.

Jaap Beernink, CEO of Novel-T: “The award of these REACT-EU grants for both specific innovation projects and for strengthening the facilities in the ecosystem are of great importance for the development of the rapidly growing MedTech cluster in Twente. Innovative growth companies are the driving force behind this. For the region, the impact of these companies is particularly large, both from a social and economic perspective.”

About MedTechTwente

MedTech Twente is the innovation hub where medical technology is accelerating. For the past 15 years, the business community and healthcare institutions have been working closely together with researchers from the knowledge institutions to develop innovations for tomorrow’s healthcare. Innovations are developed, validated and implemented in close cooperation between parties, facilitated and accelerated by supporting organisations such as Novel-T, OostNL, VitaalTwente, HIP, WTC and HealthValley. It is therefore not without reason that successful MedTech companies such as Demcon, Medspray, Micronit, Lipocoat and IAMFluidics were founded and have grown in Twente.


The European Union is working with its recovery programme EU Next Generation on a fast, green, digital and resilient recovery of the regional economy. Under the name REACT-EU, 47.5 million euros – of which 5.9 million euros government co-financing – has been made available for the East Netherlands in 2021. This amount will be awarded to projects that have successfully submitted an application by 1 April. These projects must be completed by the end of 2023 so that the regional economy can recover as quickly as possible. The extra money has therefore been made available through the existing EFRO programme OP East 2014-2020. In OP Oost, the provinces of Gelderland and Overijssel work together to stimulate smart, sustainable and future-oriented projects at companies in the East Netherlands.

Source news: Kennispark Twente

New Photonic Integration Technology Center (PITC) to advance innovations for global technological and societal challenges with revolutionary chip technology.

On 2 June 2021, the integrated photonics industry accelerator PhotonDelta, research institute TNO, Eindhoven University of Technology and University of Twente will sign a cooperation agreement for the new Photonic Integration Technology Center (PITC) in the Netherlands. This centre will speed up the commercialisation of Integrated Photonics for applications such as autonomous mobility, healthcare, data & communications. The signing will be part of an online launch event which is open to everyone who has registered through
Integrated Photonics represents a revolutionary technology that allows the development of chips that can sense, capture and process huge amounts of data using light instead of electricity. By using light we can create new types of devices and systems, complementary to those that use electronics. Photonic integrated circuits pave the way for devices and systems that are cheaper, faster, lighter, more robust and reliable while using less energy. This opens new perspectives for developing purposeful digital solutions.

Bridging the gap between research and application

The new PITC is an independent R&D and innovation centre that brings photonic technologies to industrial maturity, builds partnerships, strengthens the photonics ecosystem, and links it to a global customer base.

Accelerating commercial adoption of integrated photonics

Customers get access to technology and know-how at an early stage while sharing the costs and risk of new technology development. The jointly developed innovations will be extensively tested for reliability and stability, facilitating the route to production.

Integrated photonics is a key enabling technology with a wide spectrum of applications allowing to respond promptly and efficiently to societal challenges of today and tomorrow.” says Carlos Lee, General Director of European Photonics Industry Consortium (EPIC), “The Photonic Integration Technology Center brings the integrated photonics to a level that it can be easily adopted by industry. This great ambition makes the PITC a perfect fit to the EPIC ecosystem.”
PITC offering

Specific PITC tasks will be:

  1. Developing technology in shared innovation programs
  2. Ensuring a smooth path to manufacturing ans commercialisation
  3. Providing access to high-tech infrastructure and facilities
  4. Supporting talent development for skilled professionals that build tomorrow’s high-tech ecosystem in the Netherlands.

PITC is a cooperation between PhotonDelta, TNO, University of Twente and Eindhoven University of Technology, and is enabled by Brainport Development, the Ministry of Economic Affairs & Climate, regional growth accelerators BOM and OostNL and the provinces of Noord-Brabant, Overijssel and Gelderland. PITC is located on the premises of Eindhoven University of Technology and University of Twente in the Netherlands.

Original press release PITC

Tools for nano imaging and fabrication

On Thursday 10 June 2021 at 9.00 am Dutch time, the Dutch Embassy in Tokio is hosting a webinar ‘Tools for Nano imaging and fabrication’ on behalf of the Business Cluster Nanotechnology. The Embassy has lined up some prominent speakers for this webinar. Anyone interested can register for the webinar, so feel free to share the flyer with your contacts whether they are based in The Netherlands, Japan or elsewhere.

Download the flyer with the full program and registration link here.

A team of researchers from QuTech in the Netherlands reports realization of the first multi-node quantum network, connecting three quantum processors. In addition, they achieved a proof-of-principle demonstration of key quantum network protocols. Their findings mark an important milestone towards the future quantum internet and have now been published in Science.

The quantum internet

The power of the Internet is that it allows any two computers on Earth to be connected with each other, enabling applications undreamt of at the time of its creation decades ago. Today, researchers in many labs around the world are working towards first versions of a quantum internet – a network that can connect any two quantum devices, such as quantum computers or sensors, over large distances. Whereas today’s Internet distributes information in bits (that can be either 0 or 1), a future quantum internet will make use of quantum bits that can be 0 and 1 at the same time. ‘A quantum internet will open up a range of novel applications, from unhackable communication and cloud computing with complete user privacy to high-precision time-keeping,’ says Matteo Pompili, PhD student and a member of the research team. ‘And like with the Internet 40 years ago, there are probably many applications we cannot foresee right now.

Co-authors Matteo Pompili (left) and Sophie Hermans (right), both PhD student in the group of Ronald Hanson, at one of the quantum network nodes.

Towards ubiquitous connectivity

The first steps towards a quantum internet were taken in the past decade by linking two quantum devices that shared a direct physical link. However, being able to pass on quantum information through intermediate nodes (analogous to routers in the classical internet) is essential for creating a scalable quantum network. In addition, many promising quantum internet applications rely on entangled quantum bits, to be distributed between multiple nodes. Entanglement is a phenomenon observed at the quantum scale, fundamentally connecting particles at small and even at large distances. It provides quantum computers their enormous computational power and it is the fundamental resource for sharing quantum information over the future quantum internet. By realizing their quantum network in the lab, a team of researchers at QuTech – a collaboration between Delft University of Technology and TNO – is the first to have connected two quantum processors through an intermediate node and to have established shared entanglement between multiple stand-alone quantum processors.

Operating the quantum network

The rudimentary quantum network consists of three quantum nodes, at some distance within the same building. To make these nodes operate as a true network, the researchers had to invent a novel architecture that enables scaling beyond a single link. The middle node (called Bob) has a physical connection to both outer nodes (called Alice and Charlie), allowing entanglement links with each of these nodes to be established. Bob is equipped with an additional quantum bit that can be used as memory, allowing a previously generated quantum link to be stored while a new link is being established. After establishing the quantum links Alice–Bob and Bob–Charlie, a set of quantum operations at Bob converts these links into a quantum link Alice-Charlie. Alternatively, by performing a different set of quantum operations at Bob, entanglement between all three nodes is established.

Researchers work on one of the quantum network nodes, where mirrors and filters guide the laser beams to the diamond chip.

Ready for subsequent use

An important feature of the network is that it announces the successful completion of these (intrinsically probabilistic) protocols with a “flag” signal. Such heralding is crucial for scalability, as in a future quantum internet many of such protocols will need to be concatenated. ‘Once established, we were able to preserve the resulting entangled states, protecting them from noise,’ says Sophie Hermans, another member of the team. ‘It means that, in principle, we can use these states for quantum key distribution, a quantum computation or any other subsequent quantum protocol.’

Quantum Internet Demonstrator

This first entanglement-based quantum network provides the researchers with a unique testbed for developing and testing quantum internet hardware, software and protocols. ‘The future quantum internet will consist of countless quantum devices and intermediate nodes,’ says Ronald Hanson, who led the research team. ‘Colleagues at QuTech are already looking into future compatibility with existing data infrastructures.’ In due time, the current proof-of-principle approach will be tested outside the lab on existing telecom fibre – on QuTech’s Quantum Internet Demonstrator, of which the first metropolitan link is scheduled to be completed in 2022.

Higher-level layers

In the lab, the researchers will focus on adding more quantum bits to their three-node network and on adding higher level software and hardware layers. Pompili: ‘Once all the high-level control and interface layers for running the network have been developed, anybody will be able to write and run a network application without needing to understand how lasers and cryostats work. That is the end goal.’

Source: QuTech news item

Albert Polman, professor of nanophotonics and photovoltaics at UvA and AMOLF group leader, has received an Advanced Research Grant of 2.5 million euros from the European Research Council. Polman will use the grant to develop a new type of quantum electron microscope.

In the awarded project, Polman will use intense laser pulses to tailor the energy spectrum of high-energy electrons in a scanning electron microscope. This provides a unique way to control the quantum-mechanical electron wave packet in space and time. By combining materials excitation using these wavepackets and the detection of light that is emitted (cathodoluminescence) this creates an entirely new way of analytical electron microscopy.

ERC Advanced Research Grant

ERC Advanced Grants support excellent researchers at the career stage at which they are already established research leaders with a recognised track-record of research achievements. Candidates have to demonstrate the ground-breaking nature, ambition and feasibility of their scientific proposal. The projects must be hosted at institutions in the EU or associated countries.

The European Research Council uses the ERC Advanced grants to allow outstanding research leaders to pursue ground-breaking, high-risk projects in Europe. Read the ERC press release here.

The 4 technical universities (4TU), including the University of Twente and WUR, are joining forces with three medical academic centers and venture investor Innovation Industries to bring medical technical (medtech) solutions to the market faster. This week, the Ministries of EZK and OCW awarded 8 million euros to the medtech consortium from the Thematic Technology Transfer (TTT) scheme. This TTT scheme is best practice in Europe in the field of support for spin-offs, incubators and universities. The consortium aims to further expand the good international position of the Dutch medtech sector.

This TTT scheme is best practice in Europe in the field of support for spin-offs, incubators and universities. The consortium aims to further expand the good international position of the Dutch medtech sector.

Technological innovations are desperately needed to keep healthcare affordable, qualitative and manageable in the long term. However, the route to the market is very complex and difficult for medtech spin-offs. The Knowledge Transfer Offices (KTO) of TU Delft, TU Eindhoven, University of Twente and Wageningen University & Research, together with the KTOs of Erasmus MC, RadboudUMC and Maastricht UMC, and VC fund Innovation Industries, are building a national and open program.

Less downtime and faster to the market

“The initiative for this application comes from 4TU, with the University of Twente as lead party,” says Roy Kolkman, Manager of the KTO of the University of Twente. “With this investment we lay an excellent foundation for the medtech spin-offs in the Netherlands. By enriching the breeding ground with the right knowledge and expertise, the chance of failure is smaller and the time-to-market is shortened. ”

Better propositions

“By joining forces between UMCs and TUs, we arrive at strong propositions,” says Thijs Spigt, KTO director of Erasmus MC. “The knowledge and experience within the consortium ensures faster validation and a better business proposition. Extensive attention is paid to clinical demand, technical feasibility and business development. ”

Expansion of leading position

“The Netherlands is a frontrunner in the development of new technologies. However, bringing it to market is a major challenge. We invest in this consortium and do everything we can to make it a success. In addition to capital, we make an important contribution with our knowledge, experience and network, “says Pleuni Hooijman, fund manager at Innovation Industries.”

Source: Health Valley news

Persbericht 9 April 2021

Voor kunstmatige intelligentie, regeneratieve geneeskunde, infrastructuur voor gezondheidsdata, quantumtechnologie en waterstof/groene chemie komt vanuit het Nationaal Groeifonds 1,35 miljard euro beschikbaar. Het gaat om de bekostiging van 5 voorstellen (toekenning en reservering) voor onderzoek en innovatie die staatssecretaris Mona Keijzer (Economische Zaken en Klimaat) namens samenwerkende bedrijven, kennisinstellingen en overheden heeft ingediend.

Ze dragen volgens de onafhankelijke adviescommissie bij aan economische groei, het versterken van onderzoeks- en innovatie-ecosystemen en de internationale kennis- en concurrentiepositie van Nederland. Het besluit van de adviescommissie over de eerste ronde van het Nationaal Groeifonds is vandaag door de ministerraad overgenomen. Naast het ondersteunen van innovatiekracht zijn ook voorstellen voor het versterken van infrastructuur (IenW) en kennisontwikkeling (OCW) beoordeeld. Het ging in totaal om 15 aanvragen.

Staatssecretaris Mona Keijzer (EZK): “Innovatie gericht op digitalisering, verduurzaming en gezondheid heeft bij de start van het Nationaal Groeifonds direct een prominente plek verkregen. Dat is goed voor álle Nederlanders. Immers: onderzoek en ontwikkeling is de sleutel voor duurzame groei en dus onze banen en inkomsten van de toekomst.”

De staatssecretaris vervolgt: “De grootschalige publieke financiering voor deze vijf innovatieve toepassingen gaat een belangrijke bijdrage leveren om ons land welvarend te houden. Het is nodig dat de overheid een actievere rol op zich neemt om onderzoek, innovatie en technologie verder te laten ontwikkelen, startups te laten doorgroeien, talent aan te trekken, innovatie in Nederland te houden en daarmee onze internationale positie te versterken. Ik zie grote kansen voor de hierbij betrokken samenwerkende bedrijven, kennisinstellingen en overheden om deze uitdagingen te gaan verzilveren.”

De vijf bekostigde voorstellen vanuit onderzoek en ontwikkeling (R&D) en innovatie zijn:

Quantum Delta Nederland – 615 miljoen euro

De Nederlandse kennispositie op het gebied van quantumtechnologie behoort tot de wereldtop. Het voorstel om het ecosysteem verder uit te bouwen en om te zetten in bedrijvigheid wordt volledig bekostigd (615 miljoen euro). Quantum Delta Nederland werkt in Amsterdam, Delft, Eindhoven, Leiden en Twente met een grote coalitie bedrijven, universiteiten en andere kennisinstellingen aan het opzetten van de benodigde infrastructuur, het ontwikkelen van de technologie en aan de toepasbaarheid daarvan. Onderdeel van het plan is ook investeren in medewerkers voor de toekomst, zodat deze nieuwe sector straks direct over voldoende opgeleid personeel beschikt.

Quantumtechnologie maakt gebruik van twee principes: verstrengeling en superpositieVerstrengeling betekent dat twee deeltjes niet-fysiek verbonden zijn. Als er één verandert, verandert de ander direct mee: sneller dan het licht. Dat maakt nieuwe, extreem veilige en snelle (communicatie)netwerken mogelijk. Superpositie zorgt ervoor dat qubits, in plaats van reguliere bits die alleen of 0 of 1 kunnen zijn, 0 en 1 tegelijk zijn. Dat maakt veel rekenkracht los. Berekeningen waar de huidige computers eeuwen over zou doen, kan een quantumcomputer wel.

Quantum Delta Nederland ontwikkelt die eerste quantumcomputer die door de rekensnelheid van groot belang zijn voor efficiëntere productie of transport. Maar werkt ook aan het eerste grotere quantumnetwerk en aan quantumsensoren die in staat zijn veranderingen bij zeer kleine deeltjes te meten zoals in DNA. Een andere toekomstige bijdrage is de bijdrage aan cybersecurity via een veilig (quantum)internet.

Regeneratieve geneeskunde: RegMed XB – 56 miljoen euro

Het gevraagde bedrag voor twee biomedische innovatievoorstellen wordt volledig bekostigd. Het gaat als eerste om RegMed XB (56 miljoen euro) dat vier Nederlandse pilotfabrieken (Eindhoven, Leiden, Maastricht, Utrecht) voor de ontwikkeling van regeneratieve geneeskunde gaat bouwen. Hierin staat het herstel van schade aan cellen, weefsels en organen centraal waardoor chronische ziekten kunnen worden voorkomen of genezen.

Gezondheidszorg is een wereldwijde, groeiende markt vanwege de toenemende bevolking en vergrijzing. Effectieve behandelingen met gen- en stamceltherapie zijn dus ook een grote economische kans. Het economische doel van RegMed XB is het Nederlandse bedrijfsleven in staat te stellen om samen met onderzoekers deze innovatieve producten en processen te ontwikkelen en in te spelen op een sterk groeiende buitenlandse markt.

Health-RI: infrastructuur voor gezondheidsdata – 69 miljoen euro

Het tweede voorstel binnen het thema biomedische innovatie gaat over het opzetten van een geïntegreerde en veilige nationale gezondheidsdata-infrastructuur. Het gaat hierbij om het bundelen en hergebruiken van de Nederlandse kennis op het gebied van gezondheid, niet om een data-infrastructuur voor patiëntenzorg. Het gevraagde bedrag van 69 miljoen euro vanuit de publiek-private samenwerking Health-RI wordt ook volledig bekostigd.

Data worden nu nog versnipperd beheerd door vele zorg- en wetenschapsorganisaties zoals de Universitair Medische Centra. De krachten bundelen is essentieel om sneller en goedkoper nieuwe en effectievere (gepersonaliseerde) oplossingen te ontwikkelen voor diagnose, behandeling en preventie. De grote hoeveelheid nieuwe fundamentele kennis rond leefstijl, gezondheid en ziekte gecombineerd met een technologie als kunstmatige intelligentie (AI) draagt bij aan zowel onze gezondheid als aan Nederlandse bedrijven die hiermee actief zijn.

Opschalen van waterstof en groene elektronen in industrie – 338 miljoen euro

Het voorstel Groenvermogen is gedeeltelijk bekostigd (338 miljoen euro) en is gericht op de opschaling van waterstof en toepassing van groene elektronen in energie-intensieve industrieën. Het betreft een integrale aanpak van bedrijven, overheden en kennisinstellingen in deze sector waaronder een breed samenhangend onderzoeks- en innovatieprogramma en een onderwijsagenda. Het ontwikkelen kan bovendien sterk bijdragen aan de klimaatopgave.

De publieke investeringen moeten een krachtig en flexibel waterstofecosysteem creëren dat de basis vormt voor de opschaling van waterstof en elektrochemie. Industriële clusters waar hiervoor kansen liggen, zijn Noord-Nederland, Amsterdam, Rotterdam/Moerdijk, Zeeland, Arnhem, Brainport Eindhoven en Limburg (Chemelot).

Meer onderzoek en innovaties zijn nodig om groene waterstof uiteindelijk efficiënt en goedkoper te kunnen toepassen. Zo ontstaan ook interessante verdienmodellen voor Nederland zowel in een mogelijke rol als producent of internationale distributeur.

AiNed: investeringsprogramma kunstmatige intelligentie – 276 miljoen euro

De Nederlandse AI Coalitie (NL AIC), een publieke-private samenwerking van meer dan 250 deelnemers, heeft de eerste fase van haar investeringsvoorstel voor kunstmatige intelligentie (AI) grotendeels (276 miljoen euro) bekostigd gekregen. De ambitie van het zogenoemde AiNed-programma is om Nederland in de internationale kopgroep van landen te krijgen, zowel op het gebied van maatschappelijke voorwaarden als de economische benutting van AI.

AI kan breed worden toegepast voor bijvoorbeeld efficiëntere energiesystemen, slimmere mobiliteit en logistiek of betere zorg. Het voorstel richt zich op een gecoördineerde Nederlandse aanpak om kennis en toepasbaarheid van AI via onderzoek, innovatie, valorisatie, onderwijs te versterken én te zorgen voor mensgerichte, verantwoorde toepassing van AI in de samenleving.

De focus in de aanpak voor de versnelde toepassing van AI in Nederland ligt bij sectoren die het meeste verdienvermogen opleveren: hightech industrie, mobiliteit, logistiek, energie, gezondheid en zorg. Het strategische programma investeert daarom in het aantrekken en behouden van talentvolle AI wetenschappers, scholing en onderwijs, het ontwikkelen van maatschappelijke kaders voor toepassingen en het intensiveren van deelname in Europese programma’s waardoor er ook meer EU-geld naar Nederland komt.

Tweede ronde voor financiering vanuit Nationaal Groeifonds

In totaal diende staatssecretaris Mona Keijzer zes voorstellen namens betrokken partijen in voor de eerste ronde. Het voorstel FoodSwitch is niet gehonoreerd. Het Nationaal Groeifonds heeft aangekondigd dat er dit jaar een tweede ronde volgt waarin verbeterde én nieuwe voorstellen kunnen worden ingediend voor financiering. Onderzoek en ontwikkeling (R&D) en innovatie blijft één van de pijlers van het fonds. In totaal is er 20 miljard euro vanuit het fonds beschikbaar tot 2026, in de eerste ronde is vandaag 4 miljard euro (deels voorwaardelijk) toegekend en gereserveerd.